Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE
NCT02318342Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Dec 2014
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of warfarin in prosthetic valve thrombosis (PVT), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Frequency of patients with structural/functional abnormalities of bioprosthetic valves at 3 months. Started Dec 2014; status: recruiting.
02
Drugs
warfarin
03
Conditions
prosthetic valve thrombosis (PVT)
Beyond the preview
Go deeper on NCT02318342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318342.